Five-Year Retrospective Study Shows Topline Results for Patients Treated with Sensus Healthcare’s Superficial Radiation Therapy

Sensus Healthcare, Inc. announces topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial Radiation Therapy (SRT). The study, which was conducted across four U.S. sites, showed a 98.9 percent cure rate among 516 male and female patients.

Read the full press release here.

Share to:

Contact Us

Fill out the form below to find out more!